Current report filing

Document and Entity Information

v3.22.0.1
Document and Entity Information
Mar. 03, 2022
Cover [Abstract]  
Document Type 8-K/A
Amendment Flag true
Document Period End Date Mar. 03, 2022
Entity Registrant Name CABALETTA BIO, INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-39103
Entity Tax Identification Number 82-1685768
Entity Address, Address Line One 2929 Arch Street
Entity Address, Address Line Two Suite 600
Entity Address, City or Town Philadelphia
Entity Address, State or Province PA
Entity Address, Postal Zip Code 19104
City Area Code 267
Local Phone Number 759-3100
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.00001 per share
Trading Symbol CABA
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
Amendment Description This current report on Form 8-K/A (the “Amendment”) amends the Current Report on Form 8-K filed on March 3, 2022 by Cabaletta Bio, Inc. (the “Company”) (the “Original Form 8-K”). Slide 19, entitled MusCAARTesTM study of MuSK-CAART, was updated to clarify that a total of six subjects will need to have received the final selected dose in Part A of the study. The Amendment is amending and restating the Original Form 8-K in its entirety. 
Entity Central Index Key 0001759138